<VariationArchive RecordType="classified" VariationID="1342700" VariationName="NM_001040142.2(SCN2A):c.1528_1533del (p.Gln510_Lys511del)" VariationType="Deletion" Accession="VCV001342700" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-03-19" MostRecentSubmission="2022-03-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1334275" VariationID="1342700">
      <GeneList>
        <Gene Symbol="SCN2A" FullName="sodium voltage-gated channel alpha subunit 2" GeneID="6326" HGNC_ID="HGNC:10588" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165239414" stop="165392304" display_start="165239414" display_stop="165392304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166095911" stop="166248819" display_start="166095911" display_stop="166248819" Strand="+" />
          </Location>
          <OMIM>182390</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001040142.2(SCN2A):c.1528_1533del (p.Gln510_Lys511del)</Name>
      <CanonicalSPDI>NC_000002.12:165315609:AGAAACAGAAA:AGAAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165315610" stop="165315615" display_start="165315610" display_stop="165315615" variantLength="6" positionVCF="165315609" referenceAlleleVCF="AAGAAAC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166172120" stop="166172125" display_start="166172120" display_stop="166172125" variantLength="6" positionVCF="166172119" referenceAlleleVCF="AAGAAAC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166172125_166172130del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166172125_166172130del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.165315615_165315620del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.165315615_165315620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008143.1" sequenceAccession="NG_008143" sequenceVersion="1" change="g.81214_81219del">
            <Expression>NG_008143.1:g.81214_81219del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001040142.2" sequenceAccession="NM_001040142" sequenceVersion="2" change="c.1528_1533del" MANESelect="true">
            <Expression>NM_001040142.2:c.1528_1533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035232.1" sequenceAccession="NP_001035232" sequenceVersion="1" change="p.Gln510_Lys511del">
            <Expression>NP_001035232.1:p.Gln510_Lys511del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001040143.2" sequenceAccession="NM_001040143" sequenceVersion="2" change="c.1528_1533del">
            <Expression>NM_001040143.2:c.1528_1533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035233.1" sequenceAccession="NP_001035233" sequenceVersion="1" change="p.Gln510_Lys511del">
            <Expression>NP_001035233.1:p.Gln510_Lys511del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371246.1" sequenceAccession="NM_001371246" sequenceVersion="1" change="c.1528_1533del" MANEPlusClinical="true">
            <Expression>NM_001371246.1:c.1528_1533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358175.1" sequenceAccession="NP_001358175" sequenceVersion="1" change="p.Gln510_Lys511del">
            <Expression>NP_001358175.1:p.Gln510_Lys511del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371247.1" sequenceAccession="NM_001371247" sequenceVersion="1" change="c.1528_1533del">
            <Expression>NM_001371247.1:c.1528_1533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358176.1" sequenceAccession="NP_001358176" sequenceVersion="1" change="p.Gln510_Lys511del">
            <Expression>NP_001358176.1:p.Gln510_Lys511del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021007.3" sequenceAccession="NM_021007" sequenceVersion="3" change="c.1528_1533del">
            <Expression>NM_021007.3:c.1528_1533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066287.2" sequenceAccession="NP_066287" sequenceVersion="2" change="p.Gln510_Lys511del">
            <Expression>NP_066287.2:p.Gln510_Lys511del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2105259847" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001040142.2(SCN2A):c.1528_1533del (p.Gln510_Lys511del) AND Generalized epilepsy with febrile seizures plus" Accession="RCV001847374" Version="2">
        <ClassifiedConditionList TraitSetID="8781">
          <ClassifiedCondition DB="MedGen" ID="C3502809">Generalized epilepsy with febrile seizures plus</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-02-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-19" MostRecentSubmission="2022-03-19">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8781" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16510" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Generalized epilepsy with febrile seizures plus</ElementValue>
                <XRef ID="279665" DB="GeneTests" />
                <XRef ID="MONDO:0018214" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18641" />
                <XRef ID="18641" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <XRef ID="36387" DB="Orphanet" />
              <XRef ID="C3502809" DB="MedGen" />
              <XRef ID="MONDO:0018214" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS604233" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4106293" SubmissionDate="2022-02-20" DateLastUpdated="2022-03-19" DateCreated="2022-03-19">
        <ClinVarSubmissionID localKey="14" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002099517" DateUpdated="2022-03-19" DateCreated="2022-03-19" Type="SCV" Version="1" SubmitterName="Neurology Department, Shenzhen Children's Hospital" OrgID="508291" OrganizationCategory="laboratory" OrgAbbreviation="SZCH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001040142.1:c.1523_1528delAGAAAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA36387" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11096230</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4106293" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA36387" MappingRef="Orphanet">
        <MedGen CUI="C3502809" Name="Generalized epilepsy with febrile seizures plus" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

